Castle Biosciences (CSTL) Other Non-Current Liabilities (2019 - 2026)

Castle Biosciences (CSTL) has 8 years of Other Non-Current Liabilities data on file, last reported at $1.5 million in Q1 2026.

• Quarterly Other Non-Current Liabilities changed N/A year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (changed N/A YoY) and the FY2025 annual result came in at $1.5 million, changed N/A from the prior year.
• Other Non-Current Liabilities was little changed at $1.5 million in Q1 2026 per CSTL's latest filing, from $1.5 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $1.5 million in Q2 2025, with the low at $16000.0 in Q1 2024.
• Average Other Non-Current Liabilities over 5 years is $511615.4, with a median of $100000.0 recorded in 2022.
• Year-over-year, Other Non-Current Liabilities surged 4033.33% in 2022 and tumbled 72.22% in 2023.
• Castle Biosciences' Other Non-Current Liabilities stood at $90000.0 in 2022, then plunged by 72.22% to $25000.0 in 2023, then plunged by 36.0% to $16000.0 in 2024, then jumped by 9275.0% to $1.5 million in 2025, then changed by 0.0% to $1.5 million in 2026.
• Business Quant data shows CSTL's Other Non-Current Liabilities at $1.5 million in Q1 2026, $1.5 million in Q4 2025, and $1.5 million in Q3 2025.